Adenocarcinoma, Bronchiolo-Alveolar clinical trials
This page lists the studies that name Adenocarcinoma, Bronchiolo-Alveolar. ClinicalTrials.gov files more under this term, 103 on November 8, 2026, through its term mapping. Most others are lung cancer trials that list it among many stages and types. Carcinoma, Non-Small-Cell Lung studies →
The registry lists 27 studies for Adenocarcinoma, Bronchiolo-Alveolar across 5 countries. 0 are recruiting or about to start. 21 of them are mainly about Adenocarcinoma, Bronchiolo-Alveolar (how this is decided). Per ClinicalTrials.gov, last updated 2026-07-13.
Who runs them
National Cancer Institute (NCI) (11) · SWOG Cancer Research Network (3) · Eastern Cooperative Oncology Group (2) · Intergroupe Francophone de Cancerologie Thoracique (2) · Millennium Pharmaceuticals, Inc. (1) · SpeciCare (1) · Barbara Ann Karmanos Cancer Institute (1) · Swedish Medical Center (1)
Who these studies take
No Adenocarcinoma, Bronchiolo-Alveolar study is recruiting now.
Across all 27 studies, recruiting or not: 0% stop at 75 or younger and 0% at 65; 11% take children; 0% are for women only and 0% for men only; 4% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 27 of 27. search them.
- Chemotherapy and Radiation Therapy With or Without Metformin Hydrochloride in Treating Patients With Stage III Non-small Cell Lung CancerCompletedNCT02186847Phase 23 countries
- Treatment of Lung Adenocarcinoma With Bronchioloalveolar FeatureCompletedNCT00198380Phase 21 country
- Cetuximab in Treating Patients With Recurrent or Stage IIIB or Stage IV Lung CancerCompletedNCT00103207Phase 21 country
- Gene Therapy in Treating Patients With Non-small Cell Lung Cancer That Cannot Be Surgically RemovedCompletedNCT00003649Phase 11 country
- The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)Status unknownNCT038969581 country
- Radiation Therapy, Chemotherapy, and Soy Isoflavones in Treating Patients With Stage IIIA-IIIB Non-Small Cell Lung CancerCompletedNCT01958372Phase 11 country
- Pemetrexed Disodium With or Without Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV or Recurrent Non-Small Cell Lung CancerCompletedNCT00950365Phase 21 country
- S0635: Erlotinib and Bevacizumab in Stage IIIB and IV Bronchioloalveolar CarcinomaCompletedNCT00436332Phase 21 country
- Docetaxel, Cisplatin, Pegfilgrastim, and Erlotinib Hydrochloride in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT01557959Phase 21 country
- MK2206 and Erlotinib Hydrochloride in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Progressed After Previous Response to Erlotinib Hydrochloride TherapyCompletedNCT01294306Phase 21 country
- S0536: Cetuximab, Paclitaxel, Carboplatin, and Bevacizumab in Treating Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00368992Phase 21 country
- Therapeutic Strategy in Advanced Bronchioloalveolar CarcinomaCompletedNCT00384826Phase 21 country
- Gefitinib in Treating Patients With Stage IB, II, or IIIA Non-small Cell Lung Cancer That Was Completely Removed by SurgeryCompletedNCT00049543Phase 31 country
- Telomere Biology in Early Adenocarcinoma of the LungStatus unknownNCT022394321 country
- Bortezomib in Treating Patients With Stage IIIB or Stage IV Lung CancerCompletedNCT00118144Phase 21 country
- Bevacizumab, Paclitaxel, Carboplatin, and Radiation Therapy to the Chest in Treating Patients With Locally Advanced Non-Small Cell Lung CancerTerminatedNCT00369551Phase 11 country
- Surgery With or Without Chemotherapy in Treating Patients With Stage I Non-small Cell Lung CancerCompletedNCT00002852Phase 31 country
- Combination Chemotherapy, Radiation Therapy, and Gefitinib in Treating Patients With Stage III Non-Small Cell Lung CancerCompletedNCT00040794Phase 21 country
- Gefitinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00029003Phase 21 country
- Combination Chemotherapy and Radiation Therapy With or Without Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By SurgeryCompletedNCT00020709Phase 31 country
- Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Advanced, Metastatic, or Recurrent Non-Small Cell Lung CancerCompletedNCT00021060Phase 2/31 country
- Erlotinib and Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Inoperable Stage III Non-Small Cell Lung CancerTerminatedNCT00042835Phase 11 country
- S0526: Pemetrexed Disodium in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerTerminatedNCT00265785Phase 21 country
- S0310: Vaccine Therapy in Treating Patients With Stage IIIB or Stage IV Bronchoalveolar Lung CancerTerminatedNCT00074295Phase 2
- VELCADE in Previously Treated Patients With Stage IIIB and IV Bronchioloalveolar Carcinoma (BAC) and Adenocarcinoma With BAC FeaturesTerminatedNCT00117351Phase 21 country
- Phase II Trial of Sunitinib in BAC or Never-Smokers With Any Lung AdenocarcinomaCompletedNCT00430261Phase 21 country
- First-Line EGFR-1 Tyrosine Kinase Inhibition in Patients With NSCLC With Mutant EGFR GeneStatus unknownNCT00339586Phase 21 country